ABOUT THIS STUDY
- Must have met the inclusion criteria for preceding double-blind BID study in postherpetic neuralgia
- Must have received pregabalin/placebo under double-blind conditions for a minimum of 3 weeks.
- Patients cannot participate if they experienced a serious adverse event during
preceding double-blind BID study which was determined to be related to the study
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Bangalore, Karnataka / India
- Bangalore, Karnataka
- Mumbai, Maharashtra
- Maharashtra, Mumbai
- Chennai, Tamil Nadu
- Chennai, Tamil, Nadu